Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects of either sex in the age group between 25 years and 60 years. Subjects diagnosed with early changes of fatty liver on USG findings, only Grades I & II will be taken for the study. Both newly detected and previously diagnosed cases of NAFLD will be included.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women. Subjects diagnosed as Stage II hypertension secondary hypertension that is systolic blood pressure greater than or equal to 160 mmHg and diastolic blood pressure greater than or equal to 100 mmHg will be excluded. Subjects with confirmed complications such as uncontrolled sugar levels, HbA1c greater than 8, Cerebrovascular Accident, Myocardial Infarction, Chronic Kidney Disease, suffering from Cirrhosis, Ascites, Variceal Hemorrhage, Coagulopathy, Hepatorenal Syndrome, alcohol or other narcotic substances.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expecting improvement in USG FindingsTimepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Expecting improvement in the values of Investigations like LFT, Lipid profileTimepoint: 90 days | — |
Countries
India
Contacts
BLDEAS AVS Ayurveda Mahavidyalaya Hospital and Research Centre Vijayapura